Abstract
The immune regulatory mechanisms that modulate Th1 and Th17 immune responses are altered in multiple sclerosis (MS). The inhibitory TIM-3/Gal-9 pathwa......
小提示:本篇文献需要登录阅读全文,点击跳转登录